Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
Airflow limitation
Chronic bronchitis
Exacerbations
Innate immunity
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
19 Aug 2024
19 Aug 2024
Historique:
received:
19
12
2023
accepted:
13
08
2024
medline:
20
8
2024
pubmed:
20
8
2024
entrez:
19
8
2024
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) is a frequent cause of morbidity and mortality. Dysregulated and enhanced immune-inflammatory responses have been described in COPD. Recent data showed impaired immune responses and, in particular, of interferon (IFNs) signaling pathway in these patients. To evaluate in peripheral lung of COPD patients, the expression of some of the less investigated key components of the innate immune responses leading to IFN productions including: IFN-receptors (IFNAR1/IFNAR2), IRF-3 and MDA-5. Correlations with clinical traits and with the inflammatory cell profile have been assessed. Lung specimens were collected from 58 subjects undergoing thoracic surgery: 22 COPD patients, 21 smokers with normal lung function (SC) and 15 non-smoker controls (nSC). The expression of IFNAR1, IFNAR2, IRF-3 and MDA-5, of eosinophils and activated NK cells (NKp46+) were quantified in the peripheral lung by immunohistochemistry. A significant increase of IRF-3 + alveolar macrophages were observed in COPD and SC compared with nSC subjects. However, in COPD patients, the lower the levels of IRF-3 + alveolar macrophages the lower the FEV1 and the higher the exacerbation rate. The presence of chronic bronchitis (CB) was also associated with low levels of IRF-3 + alveolar macrophages. NKp46 + cells, but not eosinophils, were increased in COPD patients compared to nSC patients (p < 0.0001). Smoking is associated with higher levels of innate immune response as showed by higher levels of IRF-3 + alveolar macrophages and NKp46 + cells. In COPD, exacerbation rates, severe airflow obstruction and CB were associated with lower levels of IRF-3 expression, suggesting that innate immune responses characterize specific clinical traits of the disease.
Identifiants
pubmed: 39160551
doi: 10.1186/s12931-024-02952-6
pii: 10.1186/s12931-024-02952-6
doi:
Substances chimiques
Interferon Regulatory Factor-3
0
IRF3 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
315Informations de copyright
© 2024. The Author(s).
Références
Siebeler R, de Winther MPJ, Hoeksema MA. The regulatory landscape of macrophage interferon signaling in inflammation. J Allergy Clin Immunol. 2023;152:326–37.
doi: 10.1016/j.jaci.2023.04.022
pubmed: 37271317
Volpe S, Irish J, Palumbo S, Lee E, Herbert J, Ramadan I, et al. Viral infections and chronic rhinosinusitis. J Allergy Clin Immunol. 2023;152:819–26.
doi: 10.1016/j.jaci.2023.07.018
pubmed: 37574080
Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun [Internet]. 2020;1–12. https://doi.org/10.1038/s41467-020-17665-9
Contoli M, Papi A, Tomassetti L, Rizzo P, Sega FVD, Fortini F, et al. Blood Interferon-α levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients. Front Immunol. 2021;12:648004.
doi: 10.3389/fimmu.2021.648004
pubmed: 33767713
pmcid: 7985458
Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med [Internet]. 2011;183:734–42. http://www.atsjournals.org/doi/abs/ https://doi.org/10.1164/rccm.201006-0833OC
García-Valero J, Olloquequi J, Montes JF, Rodríguez E, Martín-Satué M, Texidó L et al. Deficient pulmonary IFN-β expression in COPD patients. PLoS ONE [Internet]. 2019;14:e0217803. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=31170225&retmode=ref&cmd=prlinks
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (UPDATED 2023).
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.
doi: 10.1016/j.jaci.2016.05.011
pubmed: 27373322
Hogg J, Chu F, Utokaparch S, Woods R, Elliott W, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med. 2004;350:2645–53.
doi: 10.1056/NEJMoa032158
pubmed: 15215480
Hsu AC-Y, Parsons K, Moheimani F, Knight DA, Hansbro PM, Fujita T, et al. Impaired antiviral stress granule and IFN-β enhanceosome formation enhances susceptibility to Influenza infection in Chronic Obstructive Pulmonary Disease Epithelium. Am J Respir Cell Mol Biol. 2016;55:117–27.
doi: 10.1165/rcmb.2015-0306OC
pubmed: 26807508
Chen J, Wang X, Schmalen A, Haines S, Wolff M, Ma H, et al. Antiviral CD8 + T-cell immune responses are impaired by cigarette smoke and in COPD. Eur Respir J. 2023;62:2201374.
doi: 10.1183/13993003.01374-2022
pubmed: 37385655
pmcid: 10397470
Baños-Lara MDR, Ghosh A, Guerrero-Plata A. Critical role of MDA5 in the Interferon Response Induced by Human Metapneumovirus infection in dendritic cells and in vivo. J Virol. 2013;87:1242–51.
doi: 10.1128/JVI.01213-12
pubmed: 23152520
pmcid: 3554051
Jefferies CA. Regulating IRFs in IFN Driven Disease. Front Immunol. 2019;10:325.
doi: 10.3389/fimmu.2019.00325
pubmed: 30984161
pmcid: 6449421
Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, et al. Triggering the Interferon response: the role of IRF-3 transcription factor. J Interf Cytokine Res. 1999;19:1–13.
doi: 10.1089/107999099314360
Ning S, Pagano JS, Barber GN. IRF7: activation, regulation, modification and function. Genes Immun. 2011;12:399–414.
doi: 10.1038/gene.2011.21
pubmed: 21490621
pmcid: 4437765
D’Anna SE, Maniscalco M, Carriero V, Gnemmi I, Caramori G, Nucera F, et al. Evaluation of Innate Immune mediators related to respiratory viruses in the lung of stable COPD patients. J Clin Med. 2020;9:1807.
doi: 10.3390/jcm9061807
pubmed: 32531971
pmcid: 7356645
Quatrini L, Chiesa MD, Sivori S, Mingari MC, Pende D, Moretta L. Human NK cells, their receptors and function. Eur J Immunol. 2021;51:1566–79.
doi: 10.1002/eji.202049028
pubmed: 33899224
pmcid: 9292411
Biron CA, Nguyen KB, Pien GC, Salazar-Mather PCL. TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol [Internet]. 1999;17:189–220. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10358757
Rao Y, Le Y, Xiong J, Pei Y, Sun Y. NK Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Front Immunol. 2021;12:666045.
doi: 10.3389/fimmu.2021.666045
pubmed: 34017339
pmcid: 8130558
Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A et al. Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J [Internet]. 2017;50:1700451. http://erj.ersjournals.com/lookup/doi/ https://doi.org/10.1183/13993003.00451-2017
Pavord ID, Lettis S, Anzueto A, Barnes N. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. The Lancet Respiratory [Internet]. 2016;4:731–41. https://doi.org/10.1016/S2213-2600(16)30148-5
Kolsum U, Donaldson GC, Singh R, Barker BL, Gupta V, George L et al. Blood and sputum eosinophils in COPD; relationship with bacterial load. Respir Res. 2017;1–11.
Caramori G, Casolari P, Gregorio CD, Saetta M, Baraldo S, Boschetto P, et al. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients. Histopathology. 2009;55:321–31.
doi: 10.1111/j.1365-2559.2009.03377.x
pubmed: 19723147
Scarpa MC, Baraldo S, Marian E, Turato G, Calabrese F, Saetta M, et al. Ceramide expression and cell homeostasis in Chronic Obstructive Pulmonary Disease. Respiration. 2013;85:342–9.
doi: 10.1159/000341185
pubmed: 23018286
Bazzan E, Saetta M, Turato G, Borroni EM, Cancellieri C, Baraldo S, et al. Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD. Chest. 2013;143:98–106.
doi: 10.1378/chest.11-3220
pubmed: 22797410
Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.
doi: 10.1056/NEJMoa0909883
pubmed: 20843247
Baraldo S, Turato G, Saetta M. Pathophysiology of the small airways in chronic obstructive pulmonary disease. Respiration [Internet]. 2012;84:89–97. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22868355&retmode=ref&cmd=prlinks
Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med [Internet]. 2009;360:2445–54. http://www.nejm.org/doi/abs/ https://doi.org/10.1056/NEJMra0804752
Qiu F, Liang C-L, Liu H, Zeng Y-Q, Hou S, Huang S, et al. Impacts of cigarette smoking on immune responsiveness: up and down or upside down? Oncotarget. 2016;8:268–84.
doi: 10.18632/oncotarget.13613
pmcid: 5352117
MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O’Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res [Internet]. 2007;8:84. http://respiratory-research.com/content/8/1/84
Cosio MG, Saetta M. Evasion of COPD in smokers: at what price? Eur Respir J. 2011;39:1298–303.
doi: 10.1183/09031936.00135711
pubmed: 22005915
Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III interferons. Immunity. 2019;50:907–23.
doi: 10.1016/j.immuni.2019.03.025
pubmed: 30995506
pmcid: 6839410
Byrne AJ, Mathie SA, Gregory LG, Lloyd CM. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70:1189.
doi: 10.1136/thoraxjnl-2015-207020
pubmed: 26286722
Divangahi M, King IL, Pernet E. Alveolar macrophages and type I IFN in airway homeostasis and immunity. Trends Immunol. 2015;36:307–14.
doi: 10.1016/j.it.2015.03.005
pubmed: 25843635
Vlahos R, Bozinovski S. Role of alveolar macrophages in Chronic Obstructive Pulmonary Disease. Front Immunol. 2014;5:435.
doi: 10.3389/fimmu.2014.00435
pubmed: 25309536
pmcid: 4160089
Bhatt SP, Agusti A, Bafadhel M, Christenson SA, Bon J, Donaldson GC et al. Phenotypes, Etiotypes, and endotypes of exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2023.
MacLeod M, Papi A, Contoli M, Beghe B, Celli BR, Wedzicha JA et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology [Internet]. 2021; https://onlinelibrary.wiley.com/doi/full/10.1111/resp.14041
Wilkinson TMA, Aris E, Bourne S, Clarke SC, Peeters M, Pascal TG et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax [Internet]. 2017;72:thoraxjnl-2016-209023-10. http://thorax.bmj.com/lookup/doi/ https://doi.org/10.1136/thoraxjnl-2016-209023
Singanayagam A, Loo S-L, Calderazzo MA, Finney LJ, Trujillo-Torralbo M-B, Bakhsoliani E et al. Anti-viral immunity is impaired in COPD patients with frequent exacerbations. AJP: Lung Cellular and Molecular Physiology [Internet]. 2019;190:145. https://www.physiology.org/doi/ https://doi.org/10.1152/ajplung.00253.2019
Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC. Altered effector function of peripheral cytotoxic cells in COPD. Respir Res. 2009;10:53.
doi: 10.1186/1465-9921-10-53
pubmed: 19545425
pmcid: 2705911
HODGE G, MUKARO V, HOLMES M, REYNOLDS PN. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Respirology. 2013;18:369–76.
doi: 10.1111/j.1440-1843.2012.02287.x
pubmed: 23062183
Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in Innate Immunity. Clin Rev Allergy Immunol. 2019;56:308–21.
doi: 10.1007/s12016-017-8648-x
pubmed: 28963611
Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck‐Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14:309–21.
doi: 10.1111/acel.12326
pubmed: 25720438
pmcid: 4406660
Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT. The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men. Mech Ageing Dev. 2016;156:25–33.
doi: 10.1016/j.mad.2016.04.001
pubmed: 27059724